Company news

Mdxhealth Sa (NASDAQ:MDXH) news

Mdxhealth Sa news releases on 6ix. Latest, Jun 5, 2023: MDxHealth Announces its Extraordinary General Shareholders’ Meeting

View Mdxhealth Sa →

Press releases — page 2

MDxHealth Announces its Extraordinary General Shareholders’ Meeting

June 4, 2023

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings

May 24, 2023

MDxHealth Reports Q1-2023 Results

May 14, 2023

MDxHealth to Present First Quarter 2023 Financial Results on May 15

April 30, 2023

MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings

April 24, 2023

MDxHealth Shareholder Transparency Declaration

April 6, 2023

MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank

March 12, 2023

MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023

March 7, 2023

MDxHealth Announces Update of Outstanding Shares and Voting Rights

March 7, 2023

MDxHealth Announces Exercise of Option

March 5, 2023

MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

February 21, 2023

MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar

February 14, 2023

MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test

February 12, 2023

MDxHealth Announces Pricing of Offering of ADSs in the United States

February 2, 2023

MDxHealth Announces Launch of Offering of ADSs in the United States

January 31, 2023

MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test

January 19, 2023

MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance

January 8, 2023

Mdxhealth files U.S. Shelf Registration on Form F-3

December 18, 2022

MDxHealth Provides Business Update

November 28, 2022

MDxHealth Reports Q3-2022 Results

October 26, 2022

MDxHealth Reports Half Year 2022 Results

August 24, 2022

Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results

August 1, 2022

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director

May 24, 2022

MDxHealth Reports Q1-2022 Results

April 26, 2022

MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022

March 1, 2022

MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd

February 16, 2022

MDxHealth Shareholder Transparency Declarations

November 21, 2021

MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

November 14, 2021

MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States

November 3, 2021

← Newer